Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders ...Middle East

WASHINGTON, May 24, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the Company's Board of Directors (the "Board") carefully reviewed the revised unsolicited proposal from Future Pak, LLC ("FP") to acquire the Company for $7.25 to $7.75 per...

Hence then, the article about vanda pharmaceuticals board of directors determines that revised unsolicited takeover proposal is not in the best interests of the company and its shareholders was published today ( Friday 24/05/2024 - 11:48 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders )

Also on site :

• Moltbook, a social network where AI agents hang together, may be ‘the most interesting place on the internet right now’
• World Pickleball League 2026: Mumbai Picklepower go down to Bengaluru Jawana despite Brandon Lane's heroics
• INVESTOR DEADLINE: SLM Corporation a/k/a Sallie Mae (SLM) Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces